Detalles de la búsqueda
1.
Rational design of a new antibiotic class for drug-resistant infections.
Nature;
597(7878): 698-702, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34526714
2.
Population pharmacokinetics and humanized dosage regimens matching the peak, area, trough, and range of amikacin plasma concentrations in immune-competent murine bloodstream and lung infection models.
Antimicrob Agents Chemother;
68(3): e0139423, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38289076
3.
Individual Components of Polymyxin B Modeled via Population Pharmacokinetics to Design Humanized Dosage Regimens for a Bloodstream and Lung Infection Model in Immune-Competent Mice.
Antimicrob Agents Chemother;
67(5): e0019723, 2023 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37022153
4.
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype.
Antimicrob Agents Chemother;
66(10): e0069522, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36165631
5.
Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase.
Antimicrob Agents Chemother;
65(10): e0069321, 2021 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34339275
6.
Polymyxin Susceptibility Testing and Interpretive Breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
Antimicrob Agents Chemother;
64(2)2020 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31767718
7.
First Penicillin-Binding Protein Occupancy Patterns for 15 ß-Lactams and ß-Lactamase Inhibitors in Mycobacterium abscessus.
Antimicrob Agents Chemother;
65(1)2020 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33106266
8.
Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review.
J Antimicrob Chemother;
75(6): 1374-1389, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32083674
9.
Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa.
J Infect Dis;
220(4): 666-676, 2019 07 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099835
10.
Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay.
Antimicrob Agents Chemother;
63(1)2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30397058
11.
GC-072: A Novel Therapeutic Candidate for Oral Treatment of Melioidosis and Infections Caused by Select Biothreat Pathogens.
Antimicrob Agents Chemother;
63(12)2019 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31548183
12.
Generating Robust and Informative Nonclinical In Vitro and In Vivo Bacterial Infection Model Efficacy Data To Support Translation to Humans.
Antimicrob Agents Chemother;
63(5)2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833428
13.
Comparable Efficacy and Better Safety of Double ß-Lactam Combination Therapy versus ßLactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials.
Antimicrob Agents Chemother;
63(7)2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30988147
14.
Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay.
Antimicrob Agents Chemother;
62(8)2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29866874
15.
First Penicillin-Binding Protein Occupancy Patterns of ß-Lactams and ß-Lactamase Inhibitors in Klebsiella pneumoniae.
Antimicrob Agents Chemother;
62(6)2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29712652
16.
Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia.
Antimicrob Agents Chemother;
62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038277
17.
Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a.
J Infect Dis;
214(8): 1192-7, 2016 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27496974
18.
Pharmacodynamics for antifungal drug development: an approach for acceleration, risk minimization and demonstration of causality.
J Antimicrob Chemother;
71(11): 3008-3019, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27494925
19.
Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia.
J Infect Dis;
211(8): 1326-33, 2015 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25362196
20.
Pharmacokinetic determinants of virological response to raltegravir in the in vitro pharmacodynamic hollow-fiber infection model system.
Antimicrob Agents Chemother;
59(7): 3771-7, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25870053